Virtu Financial’s Fibrocell Science Inc. FCSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-39,864
Closed -$77K 2066
2019
Q1
$77K Buy
39,864
+18,958
+91% +$37.7K ﹤0.01% 1161
2018
Q4
$31K Sell
20,906
-3,551
-15% -$7.1K ﹤0.01% 1336
2018
Q3
$58K Buy
+24,457
New +$52.8K ﹤0.01% 1281
2018
Q2
Sell
-5,299
Closed -$16K 2739
2018
Q1
$16K Sell
5,299
-12,974
-71% -$42.5K ﹤0.01% 1837
2017
Q4
$58K Buy
18,273
+11,033
+152% +$96.4K ﹤0.01% 2053
2017
Q3
$111K Buy
+7,240
New +$117K 0.01% 2047

Other funds holding FCSC

Virtu Financial's FCSC Position: Q2 2019 in Review

Virtu Financial sold out of Fibrocell Science Inc. (FCSC) in Q2 2019, closing a stake of 39,864 shares — an estimated $77K sold.

Virtu Financial first reported a position in FCSC in Q3 2017 and held it in 6 quarters. The position peaked at $111K in Q3 2017. 20 funds tracked by Wall St. Rank hold FCSC as of Q2 2019.

  • Virtu Financial reported no remaining Fibrocell Science Inc. position as of Q2 2019 after selling out during the quarter.
  • Virtu Financial sold 39,864 Fibrocell Science Inc. shares in Q2 2019, an estimated $77K.
  • Virtu Financial first reported a position in Fibrocell Science Inc. in Q3 2017 and held it in 6 quarters.
  • Virtu Financial's Fibrocell Science Inc. position peaked at $111K in Q3 2017.
  • 20 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q2 2019.

Based on Virtu Financial's 13F filing for Q2 2019, filed 13 Aug 2019.